Search - tctmd.com

Displaying 161 - 180 of 963

Sort: Relevancy | Date

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Industry News

Infraredx, a Nipro Company, Announces FDA Approval of Expanded Label Claim for the Makoto™ Intravascular Imaging System

April 22, 2019

Presentation Fellows 2019

Stent Technology:Past, Present and Future

Presenter: Gregg W. Stone

April 12, 2019

Presentation CHIP at ACC 2019

Update on PCI for Left Main and Multivessel Disease

Presenter: Gregg W. Stone

March 15, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

News Conference News CRT 2019

CABG vs PCI in Left Main Disease: The Debate Continues

Yael L. Maxwell

March 12, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

Presentation JIM 2019

Treatment of Mitral Regurgitation in Heart Failure COAPT and beyond

Presenter: Gregg W. Stone

February 14, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

Podcast TCTMD Talking Points

COAPT: A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients With Heart Failure and Secondary Mitral Regurgitation

December 12, 2018

News Daily News

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

Todd Neale

November 26, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Presenter: Felix Mahfoud, Patrick W. Serruys, Gregg W. Stone

September 25, 2018

Presentation TCT 2018

Chordal Rupture During Hemodynamic Support

Presenter: Howard C. Herrmann, Gregg W. Stone, Hadi Abu-Hantash, Vikas Aggarwal, Gary Gershony, Stefan Harb, Reginald I. Low, Francesco Maisano, Christoph A. Nienaber, Curtiss T. Stinis, Bernhard Witzenbichler

September 25, 2018

Advertisement

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Infraredx, a Nipro Company, Announces FDA Approval of Expanded Label Claim for the Makoto™ Intravascular Imaging System

Stent Technology:Past, Present and Future

Update on PCI for Left Main and Multivessel Disease

FDA Extends MitraClip Indication to Include Functional MR

CABG vs PCI in Left Main Disease: The Debate Continues

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Treatment of Mitral Regurgitation in Heart Failure COAPT and beyond

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

COAPT: A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients With Heart Failure and Secondary Mitral Regurgitation

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Chordal Rupture During Hemodynamic Support

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content